DaVita Inc. (DVA)
| Market Cap | 11.75B |
| Revenue (ttm) | 11.57B |
| Net Income (ttm) | 863.67M |
| Shares Out | 106.36M |
| EPS (ttm) | 7.43 |
| PE Ratio | 15.09 |
| Forward PE | 11.59 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 682,525 |
| Open | 111.80 |
| Previous Close | 111.47 |
| Day's Range | 111.37 - 112.76 |
| 52-Week Range | 84.14 - 136.48 |
| Beta | 1.31 |
| Analysts | Hold |
| Price Target | 140.33 (+25.1%) |
| Est. Earnings Date | Oct 28, 2021 |
About DVA
DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure or end stage renal disease (ESRD). The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also provides outpatient, hospital inpatient, and home-based hemodialysis services; owns clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers. ...
Financial Performance
In 2020, DaVita's revenue was $11.55 billion, an increase of 1.42% compared to the previous year's $11.39 billion. Earnings were $773.64 million, a decrease of -4.60%.
Financial StatementsAnalyst Forecast
According to 12 analysts, the average rating for DaVita stock is "Hold." The 12-month stock price forecast is 140.33, which is an increase of 25.06% from the latest price.
News
DaVita Climate Action Goals Approved by the Science Based Target Initiative
DENVER, Oct. 11, 2021 /PRNewswire/ -- DaVita furthers commitment to climate action goals with validation from the Science Based Targets initiative (SBTi). The organization has approved two goals: Supply...
DaVita Kidney Care Names New Chief Nursing Officer
DENVER, Sept. 16, 2021 /PRNewswire/ -- During Nephrology Nurses Week, DaVita Kidney Care begins a new chapter for its nursing program by announcing Tina Livaudais as the kidney care provider's chief nur...
DaVita Announces Dr. Gregory Moore to Join its Board of Directors
DENVER, Sept. 9, 2021 /PRNewswire/ -- DaVita Inc. announced today that its Board of Directors appointed a new independent director, Gregory Moore, M.D.
Why Is DaVita HealthCare (DVA) Down 2.3% Since Last Earnings Report?
DaVita HealthCare (DVA) reported earnings 30 days ago. What's next for the stock?
3 Warren Buffett Stocks to Buy in August
These names offer growth potential along with income.
Are Investors Undervaluing DaVita HealthCare (DVA) Right Now?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest v...
DaVita (DVA) Beats on Q2 Earnings, Raises 2021 EPS View
DaVita's (DVA) strength in dialysis patient service revenues drives its Q2 top line.
DaVita HealthCare (DVA) Q2 Earnings and Revenues Top Estimates
DaVita HealthCare (DVA) delivered earnings and revenue surprises of 23.36% and 1.37%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?
DaVita: Q2 Earnings Insights
Shares of DaVita (NYSE:DVA) moved higher in after-market trading after the company reported Q2 results. Quarterly Results Earnings per share increased 35.38% year over year to $2.64, which beat the esti...
DaVita Inc. 2nd Quarter 2021 Results
DENVER, Aug. 3, 2021 /PRNewswire/ -- DaVita Inc. (NYSE: DVA) announced financial and operating results for the quarter ended June 30, 2021. For the quarter, diluted earnings per share from continuing op...
DaVita (DVA) to Report Q2 Earnings: What's in the Offing?
Sustained momentum with respect to U.S. dialysis revenue per treatment is likely to have aided DaVita's (DVA) top line in the second quarter despite ongoing pandemic-led higher PPE costs.
DaVita HealthCare (DVA) Earnings Expected to Grow: Should You Buy?
DaVita HealthCare (DVA) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
DaVita Inc. Schedules 2nd Quarter 2021 Investor Conference Call
DENVER, July 21, 2021 /PRNewswire/ -- DaVita Inc. (NYSE: DVA), announced today that it will hold its quarterly conference call to discuss second quarter results on Tuesday, August 3, 2021, at 5:00 p.m. ...
3 Companies That Warren Buffett's Berkshire Hathaway Should Acquire
These stocks check all the right boxes for the Oracle of Omaha.
4 GARP Stocks to Scoop Up for Maximum Returns
If you're looking for a profitable portfolio of stocks that will offer the best of value and growth investing, try the growth at a reasonable price or GARP strategy.
A Look Back at Ted Weschler's Hedge Fund Holdings
In September 2011, Warren Buffett (Trades, Portfolio)'s Berkshire Hathaway ( BRK.A , Financial) ( BRK.B , Financial) announced a new investment manager would join the business to work alongside the Orac...
DVA or AMED: Which Is the Better Value Stock Right Now?
DVA vs. AMED: Which Stock Is the Better Value Option?
5 GARP Stocks for a Winning Portfolio
Growth at a reasonable price or GARP strategy helps investors gain exposure to stocks that have impressive prospects and are trading at a discount.
5 Stocks With Warren Buffett as the Largest Shareholder
Warren Buffett's Berkshire Hathaway Inc. (NYSE: BRK-B) portfolio includes nearly four dozen stocks.
Save Your Portfolio From Inflation With Four Healthcare Stocks
Healthcare stocks with long-term growth visibility can be important additions to investment portfolio when inflation runs high.
Here's Why You Should Add DaVita (DVA) Stock to Your Portfolio
Investors continue to be optimistic about DaVita (DVA) on its slew of tie-ups and strength in its kidney care business.
4 Warren Buffett Holdings Trading at Low Price-to-Free Cash Flow Ratios
According to the All-in-One Screener, a Premium feature of GuruFocus, four stocks in Berkshire Hathaway Inc.'s ( BRK.A , Financial)( BRK.B , Financial) equity portfolio that have high profitability and ...